TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30709714

Group type: EXPERIMENTAL
Intervention: Below-median intake of vitamin C
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Below-median intake of magnesium
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Below-median intake of dietary fiber
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Below-median intake of potassium
Number of subjects: 159
Study: 30555484

Group type: EXPERIMENTAL
Intervention: Normoxic training (NO)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Hypoxic training (HO)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (Normoxic vs Hypoxic)
Number of subjects: 34
Study: 26110345

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 25222702

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT) with sequential 17β-estradiol plus oral progesterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22769858

Group type: EXPERIMENTAL
Intervention: Pre-treatment group (FNB with 0.4 mL/kg 0.375% bupivacaine plus 1:200,000 epinephrine after spinal anesthesia but before the operation)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Post-treatment group (FNB with 0.4 mL/kg 0.375% bupivacaine plus 1:200,000 epinephrine immediately after the operation)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pre-control group (FNB with normal saline before the operation)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Post-control group (FNB with normal saline after the operation)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Pre-treatment group
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Post-treatment group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pre-control group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Post-control group
Number of subjects: 82
Study: 20538418

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg, 4 times/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Tramadol 200 mg, 4 times/day
Number of subjects: 9

Group type: COMPARATOR
Intervention: Morphine 15 mg, 4 times/day
Number of subjects: 9
Study: 18035292

Group type: EXPERIMENTAL
Intervention: ropivacaine 0.2%/sufentanil 1 microg/mL (group 1)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: ropivacaine 0.125%/sufentanil 1 microg/mL (group 2)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: levobupivacaine 0.125%/sufentanil 1 microg/mL (group 3)
Number of subjects: 63
Study: 16220067

Group type: EXPERIMENTAL
Intervention: Tolvaptan 30 mg QD
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tolvaptan 15 mg BID
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11751777

Group type: EXPERIMENTAL
Intervention: Quinupristin/dalfopristin (RP59500) 7.5 mg/kg infused over 1 h twice daily for 5 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Quinupristin/dalfopristin (RP59500)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10363631

Group type: EXPERIMENTAL
Intervention: Acetate free biofiltration (AFB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bicarbonate hemodialysis (HD)
Number of subjects: 20
Study: 8618812

Group type: EXPERIMENTAL
Intervention: Surgical procedures (coronary artery bypass graft, thoracic operations, cholecystectomy, inguinal hernia repair)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Surgical interventions (all groups except control)
Number of subjects: 157
Study: 1773780

Group type: EXPERIMENTAL
Intervention: LTG 240 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: LTG 120 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: PHT 1,000 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: DZP 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LTG 150 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: CBZ 600 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: CBZ 400 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: CBZ 200 mg
Number of subjects: 0
Study: 7074648

Group type: EXPERIMENTAL
Intervention: Extended field (EF) radiotherapy
Number of subjects: 460

Group type: COMPARATOR
Intervention: Involved field (IF) radiotherapy
Number of subjects: 460
Study: 30797014

Group type: EXPERIMENTAL
Intervention: Right-sided tumours
Number of subjects: 5239

Group type: EXPERIMENTAL
Intervention: Left-sided tumours
Number of subjects: 5239

Group type: EXPERIMENTAL
Intervention: Transverse tumours
Number of subjects: 5239

Group type: EXPERIMENTAL
Intervention: Stage II tumours
Number of subjects: 5239
Study: 23893533

Group type: EXPERIMENTAL
Intervention: Methylphenidate (active medication)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 46
Study: 27020901

Group type: EXPERIMENTAL
Intervention: GUI knobology control (GUIK+)
Number of subjects: 101

Group type: COMPARATOR
Intervention: No GUI knobology control (GUIK-)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Overall accuracy for fluid detection
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Comparison of test performance between groups (GUIK+ and GUIK-)
Number of subjects: 101
Study: 25082214

Group type: EXPERIMENTAL
Intervention: Positive normative message (majority physically active)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Negative normative message (majority not physically active)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group (no message)
Number of subjects: 1200
Study: 22357745

Group type: EXPERIMENTAL
Intervention: 15 g/d HAM-RS2
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 30 g/d HAM-RS2
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (0 g/d)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Overall treatments in women
Number of subjects: 33
Study: 19887342

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral protocol (nurse-led intervention)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Symptom management guide (non-nurse coach intervention)
Number of subjects: 234
Study: 17138642

Group type: EXPERIMENTAL
Intervention: Ketoprofen patch 100 mg once daily
Number of subjects: 223

Group type: COMPARATOR
Intervention: Diclofenac gel 2-4 g three times daily
Number of subjects: 223
Study: 16334075

Group type: EXPERIMENTAL
Intervention: Pharmacist-directed seamless care service
Number of subjects: 253

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 253
Study: 12466943

Group type: COMPARATOR
Intervention: Cycling (C)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Running (R)
Number of subjects: 11
Study: 9689272

Group type: EXPERIMENTAL
Intervention: Propofol anaesthesia (group PO)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol-ketamine anaesthesia (group PK)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isoflurane anaesthesia (group I)
Number of subjects: 60
Study: 7735089

Group type: EXPERIMENTAL
Intervention: Enhanced case management services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard methadone maintenance services
Number of subjects: 0
Study: 2567431

Group type: COMPARATOR
Intervention: 10 mg of salbutamol nebuliser solution in 2 ml of saline
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 10 mg of salbutamol in 2 ml (0.5 mg) of preservative‐free ipratropium bromide
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Combined treatment (salbutamol and ipratropium bromide)
Number of subjects: 103
Study: 5800365

Group type: EXPERIMENTAL
Intervention: Cigarette smoke with different filters
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Cigar tobacco smoke
Number of subjects: 91
Study: 31559532

Group type: EXPERIMENTAL
Intervention: sc IFN β‐1a 44 µg tiw
Number of subjects: 335

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study: 31033747

Group type: EXPERIMENTAL
Intervention: Therapist-guided online F-PST
Number of subjects: 150

Group type: COMPARATOR
Intervention: Self-guided online F-PST
Number of subjects: 150

Group type: COMPARATOR
Intervention: Face-to-face F-PST
Number of subjects: 150
Study: 28493891

Group type: EXPERIMENTAL
Intervention: AIDSVAX® B/E vaccine
Number of subjects: 1584

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1584
Study: 25227220

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 21
Study: 22663196

Group type: EXPERIMENTAL
Intervention: 35% PA etching→SE primer→SE adhesive (PA/SEp+a)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 35% PA etching→SE adhesive (PA/SEa)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-step self-etching adhesive (SE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etch-and-rinse adhesive (SB)
Number of subjects: 0
Study: 22128728

Group type: EXPERIMENTAL
Intervention: 150 mg dose of armodafinil
Number of subjects: 48
Study: 19406737

Group type: EXPERIMENTAL
Intervention: Systemic bevacizumab (5 mg/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (control)
Number of subjects: 16
Study: 16778338

Group type: EXPERIMENTAL
Intervention: Home Blood Pressure Measurement (HBPM)
Number of subjects: 438

Group type: COMPARATOR
Intervention: Ambulatory Blood Pressure Measurement (ABPM)
Number of subjects: 438
Study: 15259284

Group type: EXPERIMENTAL
Intervention: 1 mg of estradiol valerate (E2V) plus 2.5 mg of medroxyprogesterone acetate (MPA)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: 1 mg E2V + 5 mg MPA
Number of subjects: 393

Group type: COMPARATOR
Intervention: 2 mg estradiol (E2) and 1 mg norethisterone acetate (NETA)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: E2V/MPA regimens after dose increase
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Lower E2V dose
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 393
Study: 15559710

Group type: EXPERIMENTAL
Intervention: Team Awareness (psychosocial program)
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Informational training
Number of subjects: 587

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 587
Study: 10914173

Group type: EXPERIMENTAL
Intervention: Continued low-dose aspirin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Stopped low-dose aspirin
Number of subjects: 50
Study: 7778544

Group type: EXPERIMENTAL
Intervention: High Lp(a) levels
Number of subjects: 2424

Group type: COMPARATOR
Intervention: Intermittent claudication
Number of subjects: 2424
Study: 2330888

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 386397

Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study: 31466745

Group type: EXPERIMENTAL
Intervention: Combined radiotherapy and hyperthermia
Number of subjects: 23
Study: 28193214

Group type: EXPERIMENTAL
Intervention: CAPRI navigation program (based on two Nurse Navigators and a web portal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine delivery of oral anticancer therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CAPRI navigation program
Number of subjects: 0
Study: 25909473

Group type: EXPERIMENTAL
Intervention: Blueberry supplementation (2 cups of frozen blueberries daily for 6 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blueberry supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carrot juice drink (control group)
Number of subjects: 0
Study: 25437150

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavior therapy (ICBT) for 12 weeks
Number of subjects: 81

Group type: COMPARATOR
Intervention: Basic attention control condition
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavior therapy (ICBT)
Number of subjects: 81
Study: 22486272

Group type: EXPERIMENTAL
Intervention: Autogenous platelet concentrate (APC) applied in test defects
Number of subjects: 25

Group type: COMPARATOR
Intervention: Guided tissue regeneration (GTR) without APC in control defects
Number of subjects: 25
Study: 19282762

Group type: EXPERIMENTAL
Intervention: I‐4L model
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: TEM model
Number of subjects: 189
Study: 17639992

Group type: EXPERIMENTAL
Intervention: Xinmaitong capsule (XMT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 15646383

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (CHX) mouthrinse
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control rinse
Number of subjects: 13
Study: 12217068

Group type: EXPERIMENTAL
Intervention: Cervical manipulation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cervical manipulation with exercise
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cervical joint mobilisation
Number of subjects: 100
Study: 9640153

Group type: EXPERIMENTAL
Intervention: Size 3 laryngeal mask
Number of subjects: 60

Group type: COMPARATOR
Intervention: Size 4 laryngeal mask
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Size 4 laryngeal mask (males)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Size 5 laryngeal mask
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Removal of air to the minimum effective volume
Number of subjects: 60
Study: 8179453

Group type: EXPERIMENTAL
Intervention: Modern technology and contemporary medical practices for managing opportunistic infections in AIDS patients
Number of subjects: 0
Study: 2530507

Group type: COMPARATOR
Intervention: Indomethacin (0.36 or 0.72 mg/kg bolus followed by 0.071 or 0.143 mg/kg/hr for 150 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypertonic saline infusion (5%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin (higher dose rate)
Number of subjects: 0
Study: 30898374

Group type: EXPERIMENTAL
Intervention: Simulator training with decreased practice variability
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Greater mean scores during practice
Number of subjects: 93
Study: 28772186

Group type: EXPERIMENTAL
Intervention: Family-centred self-care educational intervention
Number of subjects: 256

Group type: COMPARATOR
Intervention: Usual care (self-care resources only)
Number of subjects: 256
Study: 26025368

Group type: EXPERIMENTAL
Intervention: Combined hygienic‐dietary written recommendations about diet, exercise, light exposure and sleep hygiene
Number of subjects: 273

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 273
Study: 23810027

Group type: EXPERIMENTAL
Intervention: Quality improvement intervention for prescribing antihypertensive medication
Number of subjects: 0
Study: 21091792

Group type: EXPERIMENTAL
Intervention: Test implant with a 1.8 mm turned neck (T)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control implant with a 2.8 mm turned neck (C)
Number of subjects: 18
Study: 19742339

Group type: EXPERIMENTAL
Intervention: GORE-TEX Dual Mesh fixing into peritoneum during sigmoid-colostomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (papillary sigmoid-colostomy through rectus abdominis and peritoneum)
Number of subjects: 60
Study: 17208639

Group type: EXPERIMENTAL
Intervention: Trastuzumab for 1 year
Number of subjects: 5102

Group type: COMPARATOR
Intervention: Observation alone (Control)
Number of subjects: 5102
Study: 14871913

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) levels
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: CRP levels
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: CRP levels at or above the 90th percentile (10.6 mg/L)
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: CRP levels at or above the mean plus 2 SDs (16.8 mg/L)
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: CRP levels for smokers
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: CRP levels for non-smokers
Number of subjects: 930
Study: 11798886

Group type: EXPERIMENTAL
Intervention: Methimazole plus L‐T(4) 50 microgram/d (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Methimazole in small dose only (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Methimazole plus L‐T(4) 50 microgram/d (Group C)
Number of subjects: 60
Study: 9931893

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (50.4 Gy) and 12 cycles of 5‐fluorouracil and medium‐dose folinic acid
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (50.4 Gy) and 6 cycles of 5‐fluorouracil and medium‐dose folinic acid
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 206
Study: 7799828

Group type: EXPERIMENTAL
Intervention: Premarin cream (0.625 mg conjugated oestrogens per gram of cream)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Premarin cream
Number of subjects: 54
Study: 2838151

Group type: EXPERIMENTAL
Intervention: Single-dose dactinomycin (60 micrograms/kg, later reduced to 45 micrograms/kg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Single-dose dactinomycin (45 micrograms/kg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Other hepatotoxic agents
Number of subjects: 5
Study: 31712087

Group type: EXPERIMENTAL
Intervention: EEG event‐related functional connectivity during processing of predictive stimuli in MDD patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: EEG event‐related functional connectivity during processing of predictive stimuli in control subjects
Number of subjects: 0
Study: 31686184

Group type: EXPERIMENTAL
Intervention: Redon drain
Number of subjects: 88

Group type: COMPARATOR
Intervention: Quadrain drain
Number of subjects: 88
Study: 28398597

Group type: EXPERIMENTAL
Intervention: Ozanimod (3 mg single dose, 2 mg/d multiple doses for 28 days)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Ozanimod (1 mg/d and 1.5 mg/d for 28 days)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Ozanimod (first dose)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Ozanimod (dose-escalation regimen)
Number of subjects: 88
Study: 26902061

Group type: EXPERIMENTAL
Intervention: Preoperative visits with nurses and conventional nursing care
Number of subjects: 240

Group type: COMPARATOR
Intervention: Conventional nursing care
Number of subjects: 240
Study: 23167508

Group type: COMPARATOR
Intervention: Corticosteroid withdrawal (CSWD)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Corticosteroid continuance (CCS)
Number of subjects: 397
Study: 21212429

Group type: EXPERIMENTAL
Intervention: Supervised exercise training
Number of subjects: 571

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 571
Study: 18079616

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of targeted agents or chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other targeted agents (tyrosine kinase inhibitors, farnesyl transferase inhibitor)
Number of subjects: 0
Study: 16432953

Group type: EXPERIMENTAL
Intervention: AMG 162 (3.0 mg/kg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: AMG 162
Number of subjects: 49
Study: 12353708

Group type: EXPERIMENTAL
Intervention: Rice starch added to bath water (twice daily for 15 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rice-starch-containing lipid-free bath formulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oil-in-water bath lotion enriched with evening primrose oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rice starch powder added to bath water
Number of subjects: 0
Study: 10203664

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 48
Study: 7887873

Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Both AR and CBT
Number of subjects: 38
Study: 2368979

Group type: EXPERIMENTAL
Intervention: Hospital diet
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hospital diet with supplementation
Number of subjects: 9
Study: 345484

Group type: EXPERIMENTAL
Intervention: Neurolept analgesia with topical anaesthesia
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Neurolept analgesia without topical anaesthesia
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Anticholinergic and topical anaesthesia with diazepam
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Anticholinergic and topical anaesthesia without diazepam
Number of subjects: 142
Study: 29734112

Group type: EXPERIMENTAL
Intervention: Self-locking stand-alone cage
Number of subjects: 98

Group type: COMPARATOR
Intervention: Cages with anterior cervical plating system
Number of subjects: 98
Study: 27117505

Group type: EXPERIMENTAL
Intervention: Hip arthroscopy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Best conservative care (personalised hip therapy)
Number of subjects: 42
Study: 25128518

Group type: EXPERIMENTAL
Intervention: Multibiomarker disease activity (MBDA) score
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Disease Activity Score (DAS)
Number of subjects: 180
Study: 22421921

Group type: EXPERIMENTAL
Intervention: Tonsillectomy (TE)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Partial intra capsular tonsillectomy/tonsillotomy (TT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Both TE and TT
Number of subjects: 76
Study: 20377533

Group type: EXPERIMENTAL
Intervention: Video-Plus (n = 168)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Standard-MD (n = 136)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Highly educated mothers (Video-Plus)
Number of subjects: 304
Study: 18693478

Group type: EXPERIMENTAL
Intervention: Iron-fortified rice (daily portion of cooked rice 5 days per week for 6 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in the abstract)
Number of subjects: 0
Study: 16471105

Group type: EXPERIMENTAL
Intervention: 1.0 MAC sevoflurane
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1.2 MAC sevoflurane
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1.4 MAC sevoflurane
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1.6 MAC sevoflurane
Number of subjects: 20